Cutaneous Oncology News

Topical synthetic hypericin ointment, activated with visible light, shows efficacy in reducing mycosis fungoides-cutaneous T-cell lymphoma lesions, according to a phase 3 study.

Jedd Wolchok, MD, PhD, FASCO, has been appointed director of Meyer Cancer Center at Weill Cornell Medicine.

Delays in melanoma treatment are associated with overall and melanoma-specific mortality, according to a study.

Brain and/or spinal MRI were effective in detecting melanin in the central nervous system of children with suspected central nervous system abnormalities, according to study findings.

Mohs micrographic surgery yielded improved survival rates and lower rates of recurrence compared with historical data for wide local excision in patients with high-risk cutaneous squamous cell carcinomas, according to study findings.

Adjunctive use of reflectance confocal microscopy for suspect melanoma lesions reduces unnecessary excisions, according to results from a clinical trial published in JAMA Dermatology.

A novel therapeutic approach targeting transforming growth factor-B1 and cyclooxygenase-2 demonstrated safety and efficacy in a small cohort of patients with cutaneous in situ squamous cell carcinoma, according to study findings.

Nonabsorbable sutures or tissue adhesives used in combination with surgical strips and liquid adhesives are safe and effective means to minimizing hyperpigmentation in skin of color following Mohs micrographic surgery, according to a study.

CLEVELAND — In this video, Jennifer Ko, MD, PhD, discusses different testing options for melanotic lesions including gene expression profiling and sequencing.

Patients older than 85 years with high functional status may benefit from Mohs surgery compared with common alternative treatments, according to data published in JAMA Dermatology.